氯沙坦的降压效应和肾脏保护作用研究(2)
第1页 |
参见附件。
[3] 王山.缬沙坦在高血压治疗中的肾脏保护作用研究[J].中外医学研究,2012,10(7):108.
[4] 梁玲.依伦平在治疗高血压合并肾损害患者中的应用[J].中国医药科学,2012,2(3):118.
[5] 万荣文,唐建军,蒋德林,等.氯沙坦和依那普利联合用药对肾性高血压的影响[J].中国医药导报,2010,7(17):51-52.
[6] Murad JP,Espinosa EV,Ting HJ,et al.Characterization of the in vivo antiplatelet activity of the antihypertensive agent losartan[J].J Cardiovasc Pharmacol Ther,2012,17(3):308-314.
[7] Mancia G,Parodi A,Merlino L,et al.Heterogeneity in antihypertensive treatment discontinuation between drugs belonging to the same class[J].J Hypertens,2011,29(5):1012-1018.
[8] Smith DH.Comparison of angiotensin Ⅱ type 1 receptor antagonists in the treatment of essential hypertension[J].Drugs,2008,68(9):1207-1225.
[9] Fuchs FD,Fuchs SC,Moreira LB,et al.A comparison between diuretics and angiotensin-receptor blocker agents in patients with stage I hypertension (PREVER-treatment trial): study protocol for a randomized double-blind controlled trial[J].Trials,2011,24(12):53.
(收稿日期:2013-04-12)
您现在查看是摘要介绍页,详见PDF附件。